About this trial
We examine patients with different autonomic neuropathies and Ehlers Danlos syndromes compared to healthy controls at three different points over time (baseline, after 3 months and after 1.5 years) to gain knowledge about the course of this disease and understand its pathophysiology, with a focus on Small Fiber neuropathy. Moreover we will validate the german version of the Malmö POTS Score and establish an easy diagnostic scheme for patients in outpatient care.
Eligibility criteria
Qualifiers
autonomic neuropathy
Postural orthostatic tachycardia syndrome
hypermobile or classical Ehlers Danlos syndromes
Chronic fatigue syndrome, mast cell activation syndrome and/or PostCOVID
Disqualifiers
pregnancy
Pacemaker or Deep brain Stimulation
sensory or motor Polyneuropathy
neurodegenerative disease
Trial design
Treatments tested in this trial
- No intervention planned, but all patients get our standart treatment
Treatment groups
Sponsors and collaborators
RWTH Aachen University
Lead sponsor
DLR German Aerospace Center
Collaborator